Posted by Michael Wonder on 22 Oct 2019
Eton Pharmaceuticals announces U.S. FDA approval of Biorphen (phenylephrine HCI) injection
22 October 2019 - Biorphen is the first and only ready-to-use FDA approved injectable formulation of phenylephrine.
Eton Pharmaceuticals today announced that the U.S. FDA has approved Biorphen, the first and only FDA approved ready-to-use formulation of phenylephrine for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anaesthesia.
